Nature Medicine, Published online: 06 August 2026; doi:10.1038/s41591-026-04541-0
In a publicly funded trial undertaken in the NHS in England, 60 adults with treatment-resistant major depression received psilocybin or placebo alongside standardized psychological support, with psilocybin showing significant improvements in depression symptoms, good tolerability and support for further research in public healthcare settings.
